Opko Health OPK Pharmaceutical — Goodwill Impaired Accumulated Impairment Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's pharmaceutical — goodwill impaired accumulated impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Opko Health's pharmaceutical — goodwill impaired accumulated impairment loss?
- Opko Health (OPK) reported pharmaceutical — goodwill impaired accumulated impairment loss of $11.7M in Q1 2026.
- What does pharmaceutical — goodwill impaired accumulated impairment loss mean?
- The cumulative total of impairment losses recognized against goodwill specifically allocated to the pharmaceutical segment. This reflects historical write-downs taken when the carrying value of the segment's goodwill exceeded its implied fair value.